Clinical Trial Update: Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing adherence to the 3HP latent tuberculosis infection regimen under self-administered therapy (SAT) versus directly observed therapy (DOT…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Latent Tuberculosis Infection

Drugs mentioned

• ISONIAZID (ISONIAZID)
• rifapentine (rifapentine)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Latent Tuberculosis Infection | Phase 3 | Status: COMPLETED | Results posted: 2025-03-13